Gorham's disease and diffuse lymphangiomatosis in children and adolescents

Rajkumar Venkatramani1, Nina S Ma, Pisit Pitukcheewanont

  • 1Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California 90027, USA.

Pediatric Blood & Cancer
|February 8, 2011
PubMed

Insights

Gorham's disease, a rare vascular disorder, can affect children. Treatment with interferon alpha-2b and bisphosphonate therapy showed disease stabilization and improvement in eight pediatric patients.

Area of Science:

  • Vascular Biology
  • Pediatric Oncology
  • Rare Diseases

Background:

  • Gorham's disease is a rare, idiopathic disorder characterized by vascular proliferation and bone resorption.
  • It is often underdiagnosed or misdiagnosed due to variable clinical presentations.
  • No established treatment guidelines exist for Gorham's disease.

Purpose of the Study:

  • To report on the clinical characteristics and treatment outcomes of pediatric patients with Gorham's disease.
  • To evaluate the efficacy of interferon alpha-2b and bisphosphonate therapy in managing this condition.
  • To highlight the association of Gorham's disease with soft tissue lymphangioma and splenic involvement in children.

Main Methods:

  • Retrospective review of eight pediatric patients diagnosed with Gorham's disease over a ten-year period.
  • Analysis of clinical data, including presence of lymphangioma and splenic involvement.
  • Assessment of treatment response to interferon alpha-2b and bisphosphonate therapy.

Main Results:

  • Seven out of eight children presented with soft tissue lymphangioma.
  • Six out of eight children had splenic involvement.
  • Disease stabilization and improvement were observed in patients treated with interferon alpha-2b and bisphosphonate therapy.

Conclusions:

  • Interferon alpha-2b and bisphosphonate therapy may be effective in managing Gorham's disease in children.
  • Early recognition and multidisciplinary management are crucial for improving outcomes.
  • Further research is warranted to establish standardized treatment protocols for Gorham's disease.

Related Concept Videos

Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...